Characteristics* | Univariant RR (95% CI) | Multivariant RR (95% CI) |
Age | ||
≤40 | 1 (reference) | 1 (reference) |
41–64 | 0.07 (0.05 to 0.09) | 0.07 (0.04 to 0.1) |
65+ | 0.3 (0.2 to 0.4) | 0.27 (0.17 to 0.4) |
Race White | 1 (reference) | 1 (reference) |
Black | 3.2 (2.6 to 4.0) | 2.9 (2.1 to 4.1) |
Hispanic | 1.9 (1.4 to 2.7) | 2.0 (1.2 to 3.1) |
Other | 2.0 (1.4 to 2.9) | 2.1 (1.2 to 3.6) |
Insurance Insured | 1 (reference) | 1 (reference) |
No insurance | 3.2 (2.2 to 4.8) | – |
Medicaid | 3.8 (2.8 to 5.2) | 2.0 (1.2 to 3.2) |
Medicare | 3.1 (2.5 to 3.8) | - |
Income | ||
<$38 000 | 1 (reference) | 1 (reference) |
$38 000–47,999 | – | – |
$48 000–62,999 | 0.7 (0.6 to 0.9) | – |
$63,000+ | 0.6 (0.5 to 0.8) | – |
Urban density | ||
Urban | 0.7 (0.5 to 1.0) | – |
Rural | - | – |
Charlson Comorbidity Index | ||
1 | – | – |
2 + | 2.0 (1.4 to 2.8) | 1.8 (1.1 to 2.9) |
FIGO Stage IA | 1 (reference) | 1 (reference) |
IB | 0.5 (0.3 to 0.7) | 0.4 (0.2 to 0.7) |
II | 2.4 (1.8 to 3.1) | 1.9 (1.3 to 2.8) |
III | 2.0 (1.5 to 2.6) | 2.7 (1.8 to 4.0) |
Grade well differentiated | 1 (reference) | 1 (reference) |
Moderate | 0.7 (0.6 to 0.9) | – |
Poorly | – | – |
Undifferentiated | – | – |
Radiation therapy | ||
External beam alone (EBRT) | 1.9 (1.5 to 2.4) | 2.7 (1.9 to 4.0) |
Brachytherapy | 0.3 (0.2 to 0.5) | 0.5 (0.2 to 0.9) |
*Non-significant covariant levels not shown.